CancerConnect
Top Stories
Newly Diagnosed
Treatment & Care
Survivorship

Brain Cancer Newsletter

TraceyS

The CancerConnect Brain Cancer Newsletter

Stay Current With Brain Cancer Treatment Advances & Connect with Others

CancerConnect Brain Cancer Newsletter

CancerConnect publishes daily cancer news, original articles and "tips" on the management of Brain Cancer. These are available in our monthly Brain Cancer newsletter.

Stay Current - Connect With Other Brain Cancer Patients

Join The CancerConnect Community: Connect with others and receive regular updates

or

Sign up for the Brain Cancer Newsletter Here

Comments

Brain

FEATURED
COMMUNITY

Overview of Brain Cancer

Symptoms, signs, diagnosis and overview of brain tumors.

Cancer Connect

The Treatment & Management of Brain Cancer

Cancer Connect - Treatment & Management of Brain Cancer

Cancer Connect

Pre-surgery Keytruda Immunotherapy Doubles Survival in Recurrent Glioblastoma

Research suggest immunotherapy may be effective treatment for glioblastoma.

MedMaven

Kinds of Brain Tumors and Cancers

Understand the various types, and the importance of "grade" in defining brain tumors.

Cancer Connect

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment.

Cancer Connect

Rindopepimut with Temodar Appears Promising in Diagnosed Glioblastoma Multiforme

Rindopepimut with Temodar Appears Promising in Newly Diagnosed Glioblastoma Multiforme

Cancer Connect

by

MedMaven

Kimberly Fowler: Brain Cancer Survivor

Kimberly Fowler: Brain Cancer Survivor.

Cancer Connect

Food & Drug Administration Grants Orphan Drug Status for WP1066 in Glioblastoma

WP1066 for glioblastoma gets FDA orphan drug designation-Approvals in Nov 2020 for pediatric brain tumors.

MedMaven

by

MedMaven

Enzastaurin for Glioblastoma

Enzastaurin and other recent developments for treating Glioblastoma.

MedMaven

Strategies to Improve Treatment of Advanced Brain Cancers

CAR T cells engineered viruses, vaccines and immunotherapy are being developed for the treatment of primary brain cancer

MedMaven